Display options
Cite
Nigam M, Hippolyte A, Dodet P, et al. Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia. J Clin Sleep Med. 2022;18(1):255-263doi: 10.5664/jcsm.9556.
Nigam, M., Hippolyte, A., Dodet, P., Gales, A., Maranci, J. B., Al-Youssef, S., Leu-Semenescu, S., & Arnulf, I. (2022). Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 18(1), 255-263. https://doi.org/10.5664/jcsm.9556
Nigam, Milan, et al. "Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia." Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine vol. 18,1 (2022): 255-263. doi: https://doi.org/10.5664/jcsm.9556
Nigam M, Hippolyte A, Dodet P, Gales A, Maranci JB, Al-Youssef S, Leu-Semenescu S, Arnulf I. Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia. J Clin Sleep Med. 2022 Jan 01;18(1):255-263. doi: 10.5664/jcsm.9556. PMID: 34314345.
Copy Download .nbib Format: NLM
Share it on

J Clin Sleep Med. 2022 Jan 01;18(1):255-263. doi: 10.5664/jcsm.9556.

Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Milan Nigam, Amandine Hippolyte, Pauline Dodet, Ana Gales, Jean-Baptiste Maranci, Saba Al-Youssef, Smaranda Leu-Semenescu, Isabelle Arnulf

Affiliations

  1. Sleep Disorders Unit, University Hospital Pitié-Salpêtrière, APHP-Sorbonne, Paris, France.
  2. Centre for Advanced Research in Sleep Medicine, Sacré-Coeur Hospital, Montreal, Quebec, Canada.
  3. Department of Neurosciences, University of Montreal, Montreal, Quebec, Canada.
  4. Sorbonne University, Paris, France.
  5. Faculté des Sciences, Université de Montpellier, Montpellier, France.
  6. Institut du Cerveau et de la Moelle (Paris Brain Institute), Paris, France.

PMID: 34314345 DOI: 10.5664/jcsm.9556

Abstract

STUDY OBJECTIVES: To assess the impact of coronavirus disease 2019 (COVID-19)-related restrictions on narcolepsy type 1 (NT2), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH).

METHODS: Participants with NT1, NT2, and IH followed in a university hospital completed an online 78-question survey assessing demographic, clinical, and occupational features of the population during the first COVID-19-related lockdown.

RESULTS: A total of 219 of 851 (25.7%) respondents of the survey reported a mean increase of 1.2 ± 1.9 hours (

CONCLUSIONS: Extended sleep time, circadian delay (in patients with IH), and teleworking resulted in decreased symptoms of central hypersomnias. These findings suggest that people with IH, NT1, and NT2 may benefit from a decrease in social and professional constraints on sleep-wake habits, and support advocacy efforts aimed at facilitating workplace and schedule accommodations for this population.

CITATION: Nigam M, Hippolyte A, Dodet P, et al. Sleeping through a pandemic: impact of COVID-19-related restrictions on narcolepsy and idiopathic hypersomnia.

© 2022 American Academy of Sleep Medicine.

Keywords: COVID-19; SARS-CoV-2; confinement; hypersomnia; lockdown; narcolepsy; teleworking

Publication Types